Ironwood Pharma (IRWD) Posts Q1 Loss of 38c/Share

Ironwood Pharma (NASDAQ: IRWD) reported Q1 EPS of ($0.38), $0.06 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $14.6 million versus the consensus estimate of $8.52 million.

For earnings history and earnings-related data on Ironwood Pharma (IRWD) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• UBS Upgrades E.ON SE (EOAN:GR) (EONGY) to Buy
• Geberit AG (GEBN:SW) (GBERY) PT Raised to CHF712 at Jefferies